NASDAQ:LEGN
Legend Biotech Corporation Stock News
$45.16
-1.21 (-2.61%)
At Close: May 17, 2024
Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript
09:43am, Thursday, 18'th Mar 2021
Legend Biotech Corporation (LEGN) CEO Ying Huang on Q4 2020 Results - Earnings Call Transcript
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
07:00am, Thursday, 18'th Mar 2021
SOMERSET, N.J.--(BUSINESS WIRE)---- $LEGN #biotech--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and developme
Legend Biotech Announces Fourth Quarter and Full-Year 2020 Earnings Conference Call
04:30pm, Wednesday, 10'th Mar 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Biotech Shares Have Soared Since 2020's Wave of IPOs
09:45am, Wednesday, 17'th Feb 2021
Indicative of investors' enthusiasm for new biotechs, the average gain in share price for the top 10 companies of the sector that went public in 2020 now tops 100%.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
SOMERSET, N.J.--(BUSINESS WIRE)-- #LegendBiotech--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and devel
Week In Review: Week's China Life Science Investments Total $800 Million
03:01pm, Sunday, 20'th Dec 2020
Overland Pharmaceuticals will form a $117 million China JV with Allogene Therapeutics to bring allogenic CAR-T drugs to China. Harbour BioMed has out-licensed its fully human SARS-CoV-2 neutralizing a
Legend Biotech to Participate in the 39th Annual J.P. Morgan Healthcare Conference
04:30pm, Tuesday, 15'th Dec 2020
SOMERSET, N.J.--(BUSINESS WIRE)-- #JPM2021--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development
Legend Biotech Added to the NASDAQ Biotechnology Index
04:30pm, Monday, 14'th Dec 2020
SOMERSET, N.J.--(BUSINESS WIRE)-- #biotech--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development
SOMERSET, N.J.--(BUSINESS WIRE)-- #LYMSM--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development o
ASH Annual Meeting: Drugmakers Battle for Multiple Myeloma
11:44am, Sunday, 13'th Dec 2020
Targeting BCMA is all the rage, but who will come out on top?
Here's the Hot Target for Multiple Myeloma Drugs
03:44pm, Saturday, 12'th Dec 2020
Drugmakers are targeting B-cell maturation antigen in different ways.
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
Legend Biotech Announces New Appointment to the Board of Directors and Resignation of Dr. Fangliang Zhang
07:00am, Monday, 23'rd Nov 2020
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel c
LEGEND BIO INVESTOR ALERT
10:18am, Sunday, 01'st Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Legend Bio To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp.
